Inhibrx Biosciences, Inc. (INBX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $124.22M | -18.6% |
| 2024 | $152.60M | -45.1% |
| 2023 | $277.92M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $124.22M | -18.6% |
| 2024 | $152.60M | -45.1% |
| 2023 | $277.92M | — |